A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
A recent study showcases the power of CRISPR gene editing to significantly boost the production of resveratrol, a ...
Research from Weill Cornell Medicine has identified a molecular pathway linking omega-6 linoleic acid—a common dietary fat in ...
As warehouses go, nuclei are more like libraries than bank vaults. Too many cellular components need access to the genome to lock it down like Fort Knox. Instead, large groupings of more than 1,000 ...
This Tucson tech company looking to make waves in the EV battery market has hired a former GM exec as chief operating officer ...
A line of strong-to-severe storms will bring damaging straight-line winds, hail, and possibly a few spin-up tornadoes to the WCCB Charlotte viewing area Monday afternoon and evening.
Discover why Immutep's Eftilagimod Alpha shows promise in NSCLC and HNSCC trials, but cautious investment is advised. Explore more details here.
This study provides proof-of-principle data for the use of trained immunity to modulate macrophage interactions with tumours. The study makes a valuable contribution to the field of trained immunity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback